🇺🇸English
Automatic translation enabled — This listing was originally written in another language and automatically translated for better readability. Please note that some details may differ from the original text.Automatic translation enabled — This listing was originally written in another language and automatically translated for better readability. Please note that some details may differ from the original text.Show original language
BerlinProduction

Pharmaceutical/chemical scale-up with GMP manufacturing authorization

Revenue€250,000
EarningsNo information
Employees10
LocationBerlin
Transaction BackgroundOther
Shares for saleMinority interest
Revenue€250,000
EarningsNo information
Employees10
LocationBerlin
Transaction BackgroundOther
Shares for saleMinority interest

Company Description

CDMO with a proprietary, patent-protected development pipeline, a GMP-compliant laboratory manufacturing license, and a pharmaceutical manufacturing license effective Q1 2026, with 10–14 employees, is seeking an investor or strategic partner.

Industry sector

Production